Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators

Chunyong Ding, Nicole M. Bremer, Thressa D. Smith, Patricia K. Seitz, Noelle Anastasio, Kathryn Cunningham, Jia Zhou

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Allosteric modulators of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) present a unique drug design strategy to augment the response to endogenous 5-HT in a site- and event-specific manner with great potential as novel central nervous system probes and therapeutics. To date, PNU-69176E is the only reported selective positive allosteric modulator for the 5-HT2CR. For the first time, an optimized synthetic route to readily access PNU-69176E (1) and its diastereomer 2 has been established in moderate to good overall yields over 10 steps starting from commercially available picolinic acid. This synthetic approach not only enables a feasible preparation of a sufficient amount of 1 for use as a reference compound for secondary pharmacological studies, but also provides an efficient synthesis of key intermediates to develop novel and simplified 5-HT2CR allosteric modulators. Compound 1 and its diastereomer 2 were functionally characterized in Chinese hamster ovary (CHO) cells stably transfected with the 5-HT 2CR using an intracellular calcium (Cai 2+) release assay. Compound 1 demonstrated efficacy and potency as an allosteric modulator for the 5-HT2CR with no intrinsic agonist activity. Compound 1 did not alter 5-HT-evoked Cai 2+ in CHO cells stably transfected with the highly homologous 5-HT2AR. In contrast, the diastereomer 2 did not alter 5-HT-evoked Cai 2+ release in 5-HT2AR-CHO or 5-HT2CR-CHO cells or exhibit intrinsic agonist activity.

Original languageEnglish (US)
Pages (from-to)538-545
Number of pages8
JournalACS Chemical Neuroscience
Volume3
Issue number7
DOIs
StatePublished - Jul 18 2012

Fingerprint

Receptor, Serotonin, 5-HT2C
Stereoisomerism
Modulators
Serotonin
Pharmacology
Cricetulus
Ovary
Drug Design
Neurology
L-threo-alpha-D-galacto-octopyranoside methyl-7-chloro-6,7,8-trideoxy-6-(((4-undecyl-2-piperidinyl)carbonyl)amino)-1-thiomonohydrochloride (2S-cis)
Assays
Central Nervous System
Cells
Calcium
Pharmaceutical Preparations

Keywords

  • 5-HT receptor
  • allosteric modulator
  • diastereomer
  • PNU-69176E
  • synthesis

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Physiology
  • Cognitive Neuroscience

Cite this

Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators. / Ding, Chunyong; Bremer, Nicole M.; Smith, Thressa D.; Seitz, Patricia K.; Anastasio, Noelle; Cunningham, Kathryn; Zhou, Jia.

In: ACS Chemical Neuroscience, Vol. 3, No. 7, 18.07.2012, p. 538-545.

Research output: Contribution to journalArticle

@article{13778fd17fee45d3a55879a1f6ba33d6,
title = "Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators",
abstract = "Allosteric modulators of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) present a unique drug design strategy to augment the response to endogenous 5-HT in a site- and event-specific manner with great potential as novel central nervous system probes and therapeutics. To date, PNU-69176E is the only reported selective positive allosteric modulator for the 5-HT2CR. For the first time, an optimized synthetic route to readily access PNU-69176E (1) and its diastereomer 2 has been established in moderate to good overall yields over 10 steps starting from commercially available picolinic acid. This synthetic approach not only enables a feasible preparation of a sufficient amount of 1 for use as a reference compound for secondary pharmacological studies, but also provides an efficient synthesis of key intermediates to develop novel and simplified 5-HT2CR allosteric modulators. Compound 1 and its diastereomer 2 were functionally characterized in Chinese hamster ovary (CHO) cells stably transfected with the 5-HT 2CR using an intracellular calcium (Cai 2+) release assay. Compound 1 demonstrated efficacy and potency as an allosteric modulator for the 5-HT2CR with no intrinsic agonist activity. Compound 1 did not alter 5-HT-evoked Cai 2+ in CHO cells stably transfected with the highly homologous 5-HT2AR. In contrast, the diastereomer 2 did not alter 5-HT-evoked Cai 2+ release in 5-HT2AR-CHO or 5-HT2CR-CHO cells or exhibit intrinsic agonist activity.",
keywords = "5-HT receptor, allosteric modulator, diastereomer, PNU-69176E, synthesis",
author = "Chunyong Ding and Bremer, {Nicole M.} and Smith, {Thressa D.} and Seitz, {Patricia K.} and Noelle Anastasio and Kathryn Cunningham and Jia Zhou",
year = "2012",
month = "7",
day = "18",
doi = "10.1021/cn300020x",
language = "English (US)",
volume = "3",
pages = "538--545",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators

AU - Ding, Chunyong

AU - Bremer, Nicole M.

AU - Smith, Thressa D.

AU - Seitz, Patricia K.

AU - Anastasio, Noelle

AU - Cunningham, Kathryn

AU - Zhou, Jia

PY - 2012/7/18

Y1 - 2012/7/18

N2 - Allosteric modulators of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) present a unique drug design strategy to augment the response to endogenous 5-HT in a site- and event-specific manner with great potential as novel central nervous system probes and therapeutics. To date, PNU-69176E is the only reported selective positive allosteric modulator for the 5-HT2CR. For the first time, an optimized synthetic route to readily access PNU-69176E (1) and its diastereomer 2 has been established in moderate to good overall yields over 10 steps starting from commercially available picolinic acid. This synthetic approach not only enables a feasible preparation of a sufficient amount of 1 for use as a reference compound for secondary pharmacological studies, but also provides an efficient synthesis of key intermediates to develop novel and simplified 5-HT2CR allosteric modulators. Compound 1 and its diastereomer 2 were functionally characterized in Chinese hamster ovary (CHO) cells stably transfected with the 5-HT 2CR using an intracellular calcium (Cai 2+) release assay. Compound 1 demonstrated efficacy and potency as an allosteric modulator for the 5-HT2CR with no intrinsic agonist activity. Compound 1 did not alter 5-HT-evoked Cai 2+ in CHO cells stably transfected with the highly homologous 5-HT2AR. In contrast, the diastereomer 2 did not alter 5-HT-evoked Cai 2+ release in 5-HT2AR-CHO or 5-HT2CR-CHO cells or exhibit intrinsic agonist activity.

AB - Allosteric modulators of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) present a unique drug design strategy to augment the response to endogenous 5-HT in a site- and event-specific manner with great potential as novel central nervous system probes and therapeutics. To date, PNU-69176E is the only reported selective positive allosteric modulator for the 5-HT2CR. For the first time, an optimized synthetic route to readily access PNU-69176E (1) and its diastereomer 2 has been established in moderate to good overall yields over 10 steps starting from commercially available picolinic acid. This synthetic approach not only enables a feasible preparation of a sufficient amount of 1 for use as a reference compound for secondary pharmacological studies, but also provides an efficient synthesis of key intermediates to develop novel and simplified 5-HT2CR allosteric modulators. Compound 1 and its diastereomer 2 were functionally characterized in Chinese hamster ovary (CHO) cells stably transfected with the 5-HT 2CR using an intracellular calcium (Cai 2+) release assay. Compound 1 demonstrated efficacy and potency as an allosteric modulator for the 5-HT2CR with no intrinsic agonist activity. Compound 1 did not alter 5-HT-evoked Cai 2+ in CHO cells stably transfected with the highly homologous 5-HT2AR. In contrast, the diastereomer 2 did not alter 5-HT-evoked Cai 2+ release in 5-HT2AR-CHO or 5-HT2CR-CHO cells or exhibit intrinsic agonist activity.

KW - 5-HT receptor

KW - allosteric modulator

KW - diastereomer

KW - PNU-69176E

KW - synthesis

UR - http://www.scopus.com/inward/record.url?scp=84863941986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863941986&partnerID=8YFLogxK

U2 - 10.1021/cn300020x

DO - 10.1021/cn300020x

M3 - Article

VL - 3

SP - 538

EP - 545

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 7

ER -